On March 5, 2025, the Federal Circuit vacated the International Trade Commission (“ITC”)’s decision and exercised its ...
In Restem, LLC v. Jadi Cell, LLC, No. 2023-2054 (Fed. Cir. Mar. 13, 2025), the Federal Circuit upheld the Patent Trial and Appeal Board’s ...
The U.S. Court of Appeals for the Federal Circuit's Rule 36 allows it to simply say a lower court or administrative decision ...
Yesterday, the U.S. Court of Appeals for the Federal Circuit issued a precedential decision vacating the Patent Trial and ...
In a precedential opinion issued on March 6, the Federal Circuit affirmed the US District Court for the Eastern District of Virginia that the claims in ImmunoGen’s US patent application 14/509,809 ...
Please enjoy the latest edition of Short Circuit, a weekly feature written by a bunch of people at the Institute for Justice. This week on the Short Circuit podcast: the panel looks at the Sixth ...
The nation’s highest patent court will rehear a case Thursday asking it to restrict the kinds of evidence expert witnesses ...
Karen Read’s defense team is challenging a federal court’s decision not to dismiss the charges against her, coming just weeks ...
Background: ImmunoGen’s Patent Application & Dispute. In 2014, ImmunoGen, Inc. (Immunogen) filed U.S. Patent Application No.
The Fourth Circuit Court of Appeals said there was no compelling reason to stay a lower court's ruling that the executive ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback